Medicaments and methods for treating headache

Details for Australian Patent Application No. 2005216887 (hide)

Owner Allergan, Inc.

Inventors Brin, Mitchell F.; Turkel, Catherine C.

Agent Davies Collison Cave

Pub. Number AU-A-2005216887

PCT Pub. Number WO2005/082339

Priority 10/789,180 26.02.04 US; 11/039,506 18.01.05 US

Filing date 15 February 2005

Wipo publication date 9 September 2005

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 39/08 (2006.01) Medicinal preparations containing antigens or antibodies - Clostridium, e.g. Clostridium tetani

Event Publications

19 October 2006 PCT application entered the National Phase

  PCT publication WO2005/082339 Priority application(s): WO2005/082339

7 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216893-Closure device

2005216883-Apparatus and method for separating a volume of composite liquid into at least two components